rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-1-8
|
pubmed:abstractText |
We investigated whether a lack of IL-10 production or responsiveness could be involved in Crohn's disease pathogenesis. Lamina propria mononuclear cells, isolated from the ilea of Crohn's disease patients (n = 16) and controls (n = 13), were activated with anti-CD3 mAb in the presence of CD80 transfectants or LPS +/- IFN-gamma. No evidence for deficient IL-10 production by either T cells or macrophages in Crohn's disease was found. However, the efficacy of rhIL-10 to down-regulate IFN-gamma and especially TNF production in cell cultures from the involved tissues of Crohn's disease patients was poor, and the use of an anti-IL-10R mAb even provided evidence for proinflammatory effects of IL-10. This lack of IL-10 effect possibly results from IL-12 activity. We conclude that IL-10 exhibits poor anti- and even potential proinflammatory effects on ileal Crohn's disease lamina propria. These data might explain the lack of therapeutic efficacy when IL-10 is given to Crohn's disease patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1521-6616
|
pubmed:author |
|
pubmed:copyrightInfo |
(c)2001 Elsevier Science.
|
pubmed:issnType |
Print
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
68-76
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11781069-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:11781069-Cells, Cultured,
pubmed-meshheading:11781069-Crohn Disease,
pubmed-meshheading:11781069-Drug Interactions,
pubmed-meshheading:11781069-Humans,
pubmed-meshheading:11781069-Ileal Diseases,
pubmed-meshheading:11781069-Interferon-gamma,
pubmed-meshheading:11781069-Interleukin-10,
pubmed-meshheading:11781069-Interleukin-12,
pubmed-meshheading:11781069-Interleukin-2,
pubmed-meshheading:11781069-Interleukin-4,
pubmed-meshheading:11781069-Macrophages,
pubmed-meshheading:11781069-Receptors, Interleukin,
pubmed-meshheading:11781069-Receptors, Interleukin-10,
pubmed-meshheading:11781069-T-Lymphocytes,
pubmed-meshheading:11781069-Tumor Necrosis Factor-alpha
|
pubmed:year |
2002
|
pubmed:articleTitle |
Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease.
|
pubmed:affiliation |
Laboratory of Experimental Immunology, University Hospital and Katholieke Universiteit Leuven, Leuven, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|